Additional file 1 of Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries

Additional file 1: Appendix Table 1. Study countries, their HTA agencies and respective perspective taken into HTA decision- making. Appendix Table 2. Information about all medicine-indication pairs (per country) studied in this analysis. Appendix Table 3. Descriptive statistics on the final funding decision outcomes after resubmission and statistical significance (p) of their HTA determinants across all sample. Appendix Table 4. Time (days) from initial to final funding decision after resubmission, and statistical significance (p) of their HTA determinants across all sample.